12:00 AM
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

GlycoMimetics preclinical data

In a mouse xenograft model of AML, GMI-1271 plus daunorubicin and cytarabine led to greater depletion of AML cells...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >